Similar articles

• Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.

  Giudicelli JF, Schmitt H, Boissier JR. Giudicelli JF, et al. J Pharmacol Exp Ther. 1969 Jul;168(1):116-26. J Pharmacol Exp Ther. 1969. PMID: 5792677 No abstract available.
• Specificity of beta-receptor antagonists.

  Raper C, Wale J. Raper C, et al. Eur J Pharmacol. 1968 Jun;3(3):279-81. doi: 10.1016/0014-2999(68)90145-3. Eur J Pharmacol. 1968. PMID: 4386266 No abstract available.
• [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].

  Nakanishi M, Imamura H, Nakamura T, Kimura T. Nakanishi M, et al. Yakugaku Zasshi. 1972 Apr;92(4):375-83. doi: 10.1248/yakushi1947.92.4_375. Yakugaku Zasshi. 1972. PMID: 4403075 Japanese. No abstract available.
• A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.

  Moore GE, O'Donnell SR. Moore GE, et al. J Pharm Pharmacol. 1970 Mar;22(3):180-8. doi: 10.1111/j.2042-7158.1970.tb08494.x. J Pharm Pharmacol. 1970. PMID: 4399485 No abstract available.
• Structure-activity relationships in the adrenergic-blocking agents.

  Ghouri MS, Haley TJ. Ghouri MS, et al. J Pharm Sci. 1969 May;58(5):511-38. doi: 10.1002/jps.2600580502. J Pharm Sci. 1969. PMID: 4389589 Review. No abstract available.